Tezcan Gecgil

Tezcan Gecgil

InvestorPlace Contributor

Expertise: ETFs, Options Trading, Technical and Fundamental Analysis

Education: PhD (Business Studies), MSc (Investment Banking & Trading), MBA

Awards & Accomplishments: Completed all 3 levels of the Chartered Market Technician (CMT) qualification

About Tezcan
Tezcan Gecgil, PhD, began contributing to InvestorPlace in 2018. She has worked in investment management in the U.S. and U.K., including a Greenwich, Connecticut-based hedge fund as well as the American Stock Exchange, CFA Institute, and Bloomberg. She has also taught at various U.S. and U.K. universities.

She holds Ph.D. (Business Studies) as well as MSc (Investment Banking & Trading) and MBA degrees from leading U.S. and U.K. universities and has also completed all three levels of the Chartered Market Technician (CMT) examination.

Her passion is for options trading based on technical analysis of fundamentally strong companies. She especially enjoys setting up weekly covered calls for income generation. Publicly, she has also contributed to investing.com and the U.K. website of The Motley Fool. She is also part of the investment management writing team at Copylab.

When not navigating the markets, Tezcan delves into the mysteries of history and explores new destinations.

Recent Articles

Why Workhorse Stock Is Back on the Road to $30

By Tezcan Gecgil, InvestorPlace Contributor

WKHS stock will likely benefit from the Biden administration's potential green energy movement. This will turbocharge many EV companies.

Nio Stock Deserves a Spot In Long-Term Portfolios

By Tezcan Gecgil, InvestorPlace Contributor

Nio stock may come under further pressure, which would make the shares of the unstoppable EV company an even better value in the long-run.

Landcadia Holdings II Joins a Hot Market, But Comes With Risks

By Tezcan Gecgil, InvestorPlace Contributor

Investors should keep LCA stock on their radar screen, as online gambling is expected to grow steadily in the coming years.

Without Positive Vaccine News, Novavax May Fall Further

By Tezcan Gecgil, InvestorPlace Contributor

NVAX stock is likely to stay under further pressure until it can release more positive clinical data

EV Play Hyliion Stock Is Still a Really Risky Proposition

By Tezcan Gecgil, InvestorPlace Contributor

Hyliion stock may not be able to create much shareholder value in the coming quarters

3 Marijuana Stocks That Won’t Last the Next 4 Years

By Tezcan Gecgil, InvestorPlace Contributor

Faint-of-heart investors should possibly keep away from these troubled marijuana stocks that may not last forever.

7 Healthcare Stocks That Can Survive Massive Reform

By Tezcan Gecgil, InvestorPlace Contributor

These seven healthcare stocks may represent robust long-term investments no matter how reforms in the sector may develop post-election.

3 Election Stocks To Buy For A Drawn-Out U.S. Vote

By Tezcan Gecgil, InvestorPlace Contributor

Elections may feel divisive, but these three election stocks should help investors ride out any potential storm this year in the U.S.

3 Biotech Stocks With Eye-Catching Pipelines

By Tezcan Gecgil, InvestorPlace Contributor

Investing in biotech stocks may feel daunting to many investors, but these three stocks deserve to be on your watchlist.

RUN Will Benefit From Sunrun’s Position As a Leading Solar Company

By Tezcan Gecgil, InvestorPlace Contributor

Sunrun's recent acquisition of Vivint Solar will likely mean further synergies, which should support RUN stock.

Load More